Purple Biotech Q2 EPS $(0.35) Beats $(0.98) Estimate
Purple Biotech (NASDAQ:PPBT) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.98) by 64.29 percent. This is a 91.25 percent increase over losses of $(4.00) per share from
Purple Biotech lost less money than experts predicted—a big improvement from last year's much bigger losses. When a company loses less than people expected, it can be a sign things are getting better, so that's worth paying attention to.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.